The stimulation of peripheral mu opioid receptors leads to adverse effects, such as constipation, which results from stimulation of gastrointestinal mu opioid receptors, while the adverse effects of nausea, vomiting, respiratory depression, and tolerance are mediated via mu receptors in the CNS [11]. Here, OPRM1 is linked to Respiratory insufficiency due to muscle weakness.